Compound 21, a selective agonist of angiotensin AT(2) receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo

BACKGROUND AND PURPOSE: Angiotensin AT (2) receptors are upregulated in disease states such as atherosclerosis and blockade of the AT(2) receptors exacerbates plaque formation. Direct stimulation of these receptors is anti‐atherogenic but the mechanisms and pathways involved remain unknown. We exami...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Br J Pharmacol
Κύριοι συγγραφείς: Sampson, Amanda K, Irvine, Jennifer C, Shihata, Waled A, Dragoljevic, Dragana, Lumsden, Natalie, Huet, Olivier, Barnes, Tyrone, Unger, Thomas, Steckelings, Ulrike M, Jennings, Garry L, Widdop, Robert E, Chin‐Dusting, Jaye P F
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: John Wiley and Sons Inc. 2015
Θέματα:
Themed Section: Research Papers
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4742292/
https://ncbi.nlm.nih.gov/pubmed/25560767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13063
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια